Genetic markers in diabetes mellitus: the need and promise for specific drug therapies in defined subtypes of diabetes patients

Author： Smith Robert J  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.7, Iss.4, 2010-07, pp. : 309-312

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life of patients with diabetes mellitus

By Wändell Per  

Scandinavian Journal of Primary Health Care, Vol. 23, Iss. 2, 2005-06 ,pp. : 68-74

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Tuberculosis in Patients with Diabetes mellitus

By  

Respiration, Vol. 68, Iss. 6, 2001-12 ,pp. : 595-600

Karger

Access to resources Recommend Favorite

Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with Type 2 diabetes mellitus

By Mojiminiyi O. A.   Abdella N.   George S.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 60, Iss. 6, 2000-11 ,pp. : 483-489

Informa Healthcare

Access to resources Recommend Favorite

Bone remodelling markers in hypertensive patients with and without diabetes mellitus: link between bone and glucose metabolism

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 1520-7552, Iss. 7, 2015-10 ,pp. : 752-757

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bone remodelling markers in hypertensive patients with and without diabetes mellitus: link between bone and glucose metabolism

By  

DIABETES/METABOLISM: RESEARCH AND REVIEWS (ELECT), Vol. 31, Iss. 7, 2015-10 ,pp. : 752-757

John Wiley & Sons Inc

Access to resources Recommend Favorite